Relationships between behavioural states and activity of the cerebral cortex.
D000818:Animals; D001127:Arginine Vasopressin / Q000008:administration & dosage / Q000494:pharmacology; D001143:Arousal / Q000502:physiology; D001522:Behavior, Animal / Q000502:physiology*; D001696:Biomechanical Phenomena; D002490:Central Nervous System / Q000187:drug effects; D002540:Cerebral Cortex / Q000166:cytology / Q000502:physiology*; D004569:Electroencephalography; D004594:Electrophysiology; D004967:Estrogens / Q000502:physiology; D007031:Hypothalamus / Q000378:metabolism; D007276:Injections, Intraventricular; D007279:Injections, Subcutaneous; D008322:Mammals; D008959:Models, Neurological; D009474:Neurons / Q000502:physiology; D018377:Neurotransmitter Agents / Q000502:physiology; D010121:Oxytocin / Q000502:physiology; D010455:Peptides / Q000378:metabolism / Q000502:physiology; D010902:Pituitary Gland / Q000378:metabolism; D012890:Sleep / Q000502:physiology; D014851:Wakefulness / Q000502:physiology
D004967:Estrogens; D018377:Neurotransmitter Agents; D010455:Peptides; D001127:Arginine Vasopressin; D010121:Oxytocin